Is Psykey, Inc. (CEOS) a Buy, Sell, or Hold?
OTC : CEOS
Psykey, Inc.
$0.00738 USD
$0 (0.0%)
- Volume
- 25K
- Average Volume
- 148.25K
- Market Capitalization
- $2.31M
- P/E Ratio
- 0.81
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.01
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.77
Company Overview
OTC
Michael Maher
Medical - Instruments & Supplies
Healthcare
CEOS
6
CA
USD
Liquidity Metrics
0.00
1.77
1.77
0.31
0.00
Sales & Valuation
-$
0.00
1.35
2.20
0.00
Profitability
$0.0091
$3.12M
0.00%
0.00%
733.40%
85.50%
P/E Metrics
0.81
-0.01
-0.01
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
0.44
6/9
$896.46K
$3.23M
$1.77M
-$1.33M
Key Metrics (TTM)
$1.76M
0.00
-0.90
1.77
733.40%
-104.59%
123.67%
45.39%
$0.03
0 days
Company Executives
| Name | Title |
|---|---|
| Michael Maher | Interim Chief Executive Officer |
| Sukhinder Kalsi | Co-Founder, Chief Financial Officer, Treasurer & Director |
| Amar Singh Bhatal | Co-Founder, President, Secretary & Director |
| John Gustin | Head of Global Business Development |
| Guy Patrick Ratchford | President, Secretary, Acting Principal Executive, Financial and Accounting officer & Director |
| Mark Perkell | Vice President and General Counsel |
| Jacqueline Rae Danforth | Compliance Officer & Accountant |
Poll Results
No votes yet today — be the first to share your view!
About Psykey, Inc. (OTC:CEOS) Stock
Psykey, Inc. is dedicated to the exploration, formulation, and market introduction of specialized ingredients and compounds, including entheogenic, adaptogenic, and nootropic substances. These are incorporated into its functional product lines, which aim to enhance and optimize overall well-being. Furthermore, the company develops cutting-edge technologies focused on the makeup, bioavailability, and targeted administration of entheogen-derived therapeutics within the burgeoning psychedelic industry. Among its consumer offerings are functional mushroom coffees and teas, a variety of oral supplements, and convenient single-serve beverage mixes. The entity, which was established in Toronto, Canada, in 2002, previously operated as CeCors, Inc. before officially adopting the name Psykey, Inc. i ... n August 2021.
Frequently Asked Questions
-
What is the current Psykey, Inc. (CEOS) stock price?
-
Psykey, Inc.(OTC:CEOS) stock price is $0.00738 in the last trading session. During the trading session, CEOS stock reached the peak price of $0.0101 while $0.0006 was the lowest point it dropped to. The percentage change in CEOS stock occurred in the recent session was 0.0% while the dollar amount for the price change in CEOS stock was $0.
-
CEOS's industry and sector of operation?
-
The OTC listed CEOS is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of CEOS?
-
Michael Maher | Interim Chief Executive Officer
Sukhinder Kalsi | Co-Founder, Chief Financial Officer, Treasurer & Director
Amar Singh Bhatal | Co-Founder, President, Secretary & Director
John Gustin | Head of Global Business Development
Guy Patrick Ratchford | President, Secretary, Acting Principal Executive, Financial and Accounting officer & Director -
How many employees does CEOS have?
-
Number of CEOS employees currently stands at 6. CEOS operates from 17 Belfield Road, Toronto, ON M9W1E8, CA.
-
Link for CEOS official website?
-
Official Website of CEOS is: https://www.psykeyworld.com
-
How do I contact CEOS?
-
CEOS could be contacted at phone #888 376 8258 and can also be accessed through its website. CEOS operates from 17 Belfield Road, Toronto, ON M9W1E8, CA.
-
How many shares of CEOS are traded daily?
-
The average number of CEOS shares traded daily for last 3 months was 148.25K.
-
What is the market cap of CEOS currently?
-
The market value of CEOS currently stands at $2.31M with its latest stock price at $0.00738